Works matching IS 00207136 AND DT 2023 AND VI 152 AND IP 1


Results: 12
    1

    Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 1, p. 79, doi. 10.1002/ijc.34239
    By:
    • Gao, Guanghui;
    • Cui, Longgang;
    • Zhou, Fei;
    • Jiang, Tao;
    • Wang, Wanying;
    • Mao, Shiqi;
    • Wu, Fengying;
    • Jiang, Fangli;
    • Zhang, Bei;
    • Bei, Ting;
    • Xie, Wenchuan;
    • Zhang, Cheng;
    • Zhang, Hougang;
    • Gao, Chan;
    • Zhao, Xiaochen;
    • Bai, Yuezong;
    • Zhou, Caicun;
    • Ren, Shengxiang
    Publication type:
    Article
    2

    Guest Editor.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 1, p. 6, doi. 10.1002/ijc.34341
    By:
    • Qin, Shukui
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Special issue "The advance of solid tumor research in China": Multi‐omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 1, p. 66, doi. 10.1002/ijc.34121
    By:
    • Tian, Xi;
    • Wang, Yue;
    • Xu, Wenhao;
    • Tang, Haidan;
    • Zhu, Shuxuan;
    • Anwaier, Aihetaimujiang;
    • Liu, Wangrui;
    • Wang, Wenfeng;
    • Zhu, Wenkai;
    • Su, Jiaqi;
    • Qu, Yuanyuan;
    • Zhang, Hailiang;
    • Ye, Dingwei
    Publication type:
    Article
    9

    Issue Information.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 1, p. 100, doi. 10.1002/ijc.34064
    Publication type:
    Article
    10

    Issue Information.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 1, p. 1, doi. 10.1002/ijc.34063
    Publication type:
    Article
    11
    12